Close

Threshold Pharma (THLD) Posts Q4 Loss of 12c/Share

March 3, 2015 8:51 AM EST

Threshold Pharma (NASDAQ: THLD) reported Q4 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $4.1 million.

For earnings history and earnings-related data on Threshold Pharma (THLD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings